Retrospective survey reveals significant dose differences in infants and supports future standards for safety.
Weight-stratified institutional typical values revealed critical disparities, notably a five-fold higher dose for therapeutic procedures in infants <5 kg (4.07 vs 0.80 Gy·cm2). While weight predicts diagnostic dose, complexity drives therapeutic exposure. These benchmarks enable local optimization and support future National DRL development.
No takes yet. Share an insight, caveat, or question.
Cerda et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: